A Dose Escalation Study of IN-105 (Insulin Analogue) Tablets in Type 2 Diabetes Mellitus Subjects

被引：0
|
作者：
Iyer, Harish
Khedkar, Anand
Verma, Manish
Krishnamurthy, Sharmitha
Anand, Arun
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A117 / A117
页数：1
相关论文
共 50 条
  • [1] A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects
    Khedkar, A.
    Iyer, H.
    Anand, A.
    Verma, M.
    Krishnamurthy, S.
    Savale, S.
    Atignal, A.
    DIABETES OBESITY & METABOLISM, 2010, 12 (08): : 659 - 664
  • [2] First Human Dose Escalation Study with Remogliflozin Etabonate (RE) in Healthy Subjects and in Subjects with Type 2 Diabetes Mellitus (T2DM)
    Kapur, Anita
    O'Connor-Semmes, Robin L.
    Hussey, Elizabeth K.
    Dobbins, Robert L.
    Tao, Wenli
    Hompesch, Marcus
    Nunez, Derek J.
    DIABETES, 2009, 58 : A136 - A136
  • [3] Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus
    Ersoy, A
    Ersoy, C
    Altinay, T
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (02) : 553 - 554
  • [4] An open label, two period, placebo controlled, multiple dose study to evaluate the effect of food on pharmacokinetic and pharmacodynamic of IN-105 10 mg in type 2 diabetes mellitus patients
    Iyer, H.
    Khedkar, A. P.
    Suryanarayan, S.
    Anand, A.
    Vedala, A.
    Krishnamurthy, S.
    Arvind, A. S.
    Eshwaraiah, A.
    Savale, S.
    Kumar, K. M. Prasanna
    Arvind, S. R.
    Srikanta, S. S.
    DIABETOLOGIA, 2008, 51 : S8 - S8
  • [5] Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
    Ametov, A. S.
    Chernikova, N. A.
    DIABETES MELLITUS, 2012, 15 (04): : 89 - 94
  • [6] Intensifying Insulin Therapy in Type 2 Diabetes Mellitus: Dosing Options for Insulin Analogue Premixes
    Tibaldi, Joseph M.
    CLINICAL THERAPEUTICS, 2011, 33 (11) : 1630 - 1642
  • [7] Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
    Choe, Eun Yeong
    Lee, Yong-Ho
    Lee, Byung-Wan
    Kang, Eun-Seok
    Cha, Bong Soo
    Lee, Hyun Chul
    DIABETES & METABOLISM JOURNAL, 2012, 36 (03) : 230 - 236
  • [8] Urinary Iodine is Associated with Insulin Resistance in Subjects with Diabetes Mellitus Type 2
    Al-Attas, O. S.
    Al-Daghri, N. M.
    Alkharfy, K. M.
    Alokail, M. S.
    Al-Johani, N. J.
    Abd-Alrahman, S. H.
    Yakout, S. M.
    Draz, H. M.
    Sabico, S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2012, 120 (10) : 618 - 622
  • [9] Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial
    Liebl, A.
    Prager, R.
    Binz, K.
    Kaiser, M.
    Bergenstal, R.
    Gallwitz, B.
    DIABETES OBESITY & METABOLISM, 2009, 11 (01): : 45 - 52
  • [10] Is FPG variability linked to dose escalation during basal insulin titration, leading to excess insulin, weight gain and hypoglycaemia in type 2 diabetes mellitus?
    King, A. B.
    Stewart, J.
    Vlajnic, A.
    Liang, J.
    DIABETOLOGIA, 2013, 56 : S411 - S411
12345